Response to article titled “US-funded measurements of cervical cancer death rates in India: scientific and ethical concerns” by Eric J Suba

Rengaswamy Sankaranarayanan, Bhagwan M Nene, Surendra Shastri, Pullikotil Ekkuru Esmy, Rajamanickam Rajkumar, Richard Muwonge, Rajaraman Swaminathan, Sylla G Malvi, Shubada Kane, Sangeeta Desai, Rohini Kelkar, Sanjay Hingmire, Kasturi Jayant

DOI: 10.20529/IJME.2014.045


Dr Eric Suba has been distorting facts and persistently disseminating biased and misleading views and statements regarding our studies over the past several years. His article in the Indian Journal of Medical Ethics fails to mention the facts that seem unfavourable to his arguments, and the ethical concerns are unsubstantiated by the evidence. In this context, we present the following clarifications for the attention of your readers, notably with regard to: (i) the study design and inclusion of a control group; (ii) the informed consent of the women participating in the study; (iii) the conformity with international ethical standards and guidelines, and (iv) the provision of screening to women in the control arm of the studies. We also highlight the benefits that are flowing from this research and the risk that misinformation may further delay access for women to life-saving cervical cancer screening.

Full Text





There are currently no refbacks.